MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $166,126 | -30.8% | 10,357 | 0.0% | 0.04% | -30.2% |
| Q2 2023 | $240,075 | -0.2% | 10,357 | 0.0% | 0.06% | -4.5% |
| Q1 2023 | $240,593 | +60.1% | 10,357 | 0.0% | 0.07% | +53.5% |
| Q4 2022 | $150,280 | -24.1% | 10,357 | 0.0% | 0.04% | -29.5% |
| Q3 2022 | $198,000 | +5.3% | 10,357 | 0.0% | 0.06% | -3.2% |
| Q2 2022 | $188,000 | -28.0% | 10,357 | 0.0% | 0.06% | -19.2% |
| Q1 2022 | $261,000 | -8.7% | 10,357 | 0.0% | 0.08% | -8.2% |
| Q4 2021 | $286,000 | -14.4% | 10,357 | 0.0% | 0.08% | -18.3% |
| Q3 2021 | $334,000 | +5.4% | 10,357 | 0.0% | 0.10% | +4.0% |
| Q2 2021 | $317,000 | +0.6% | 10,357 | 0.0% | 0.10% | -5.7% |
| Q1 2021 | $315,000 | -5.4% | 10,357 | -38.6% | 0.11% | -11.7% |
| Q4 2020 | $333,000 | +51.4% | 16,857 | 0.0% | 0.12% | +41.2% |
| Q3 2020 | $220,000 | +15.2% | 16,857 | 0.0% | 0.08% | +6.2% |
| Q2 2020 | $191,000 | -20.7% | 16,857 | 0.0% | 0.08% | -29.8% |
| Q1 2020 | $241,000 | -25.4% | 16,857 | +42.2% | 0.11% | -16.8% |
| Q4 2019 | $323,000 | – | 11,857 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |